A Study for Patient With Chronic Low Back Pain
CompletedPhase 3NCT00767806
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The purpose of this study is to determine if duloxetine reduces the severity of chronic low back pain.
Study details
- Official title
- Effect of Duloxetine 60 mg Once Daily Versus Placebo in Patients With Chronic Low Back Pain
- Conditions
- Interventions
- Sponsor
- Eli Lilly and Company
- Start date
- 2008-09
- Primary completion
- 2009-07
- Sex
- All
- Age range
- from 18 Years
- Results posted
- Yes, on ClinicalTrials.gov
- Countries
- Brazil, Germany, Netherlands, Poland, Russia, Spain, United States
- Total sites listed
- 26
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Male or female outpatients with chronic low back pain Exclusion Criteria: * Cardiovascular, hepatic, renal, respiratory, or hematologic illness, or other medical or psychiatric condition that, in the opinion of the investigator, would compromise participation or be likely to lead to hospitalization during the course of the study. * Acute liver injury (such as hepatitis) or severe cirrhosis. * Previous exposure to duloxetine. * Body Mass Index (BMI) over 40. * Major depressive disorder. * Daily use of narcotics.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT00767806